Pulmonology Coding Alert

Get injection coding on track for Medicare and non-Medicare patients

Before you report the newly introduced Xolair (also known as Omalizumab) agent for injections, consider where your practice bought the agent, how many doses your pulmonologist administered to the asthma patient, and which carrier you are billing for the Xolair administration.

Warning: Failing to note these specific details could take you down the road to denials. Use the easy-to-follow flow chart above, reviewed by Denita Johnson, a coding auditor for Respiratory & Critical Care Consultants in Indianapolis, the next time you face your Xolair injection coding woes for patients who have moderate-to-severe persistent asthma.